Barbara Lippert's Critique

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

Speaking of injectable, watered-down botulism (and who isn’t?), there’s been lots of buzz lately about Botox, the neurotoxin secretly used on crow’s feet and creases by the aging rich and famous. Now that the stuff has been FDA-approved for cosmetic use by a company called Allergan, analysts predict Botox revenue could quadruple in the next two years.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in